Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 2/20 | 0.37 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10733624 | 0.70 | CALM1 (0.50) | CALM1DAOSORT1MAOBMAOA | |
| SCHEMBL9569910 | 0.69 | PTPN1 (0.40) | CALM1DAOSORT1MAOBMAOA | |
| SCHEMBL6495081 | 0.68 | SORT1 (0.44) | CALM1DAOSORT1MAOBMAOA | |
| SCHEMBL11463466 | 0.67 | CALM1 (0.41) | CALM1DAOSORT1MAOBMAOA | |
| SCHEMBL8718613 | 0.66 | MAPT (0.39) | ALDH1A1KMT2AHPGDMEN1KDM4E | |
| SCHEMBL2681077 | 0.65 | CALM1 (0.44) | CALM1DAOSORT1MAOBMAOA | |
| SCHEMBL8132266 | 0.64 | CALM1 (0.55) | CALM1DAOSORT1MAOBMAOA | |
| SCHEMBL196532 | 0.64 | MAOA (0.44) | CALM1DAOSORT1MAOBMAOA | |
| Diphenylmethane SCHEMBL3792579 | 0.64 | CALM1 (1.00) | CALM1MAOBALDH1A1HPGDIDH1 | |
| Diphenylmethane SCHEMBL14763944 | 0.64 | CALM1 (1.00) | CALM1MAOBALDH1A1HPGDIDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8293778-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2012-10-23 | — | — | US | disclosed |
| EP-1773790-B1 | BENZYLTRIAZOLONE COMPOUNDS AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2012-08-15 | — | — | EP | disclosed |
| US-20110207688-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | DUNN JAMES PATRICK | 2011-08-25 | — | — | US | disclosed |
| CN-1993332-B | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC | 2011-04-06 | — | — | CN | disclosed |
| CN-1993332-B | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC | 2011-04-06 | — | — | CN | disclosed |
| US-7666891-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2010-02-23 | — | — | US | disclosed |
| CN-1993332-A | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (CH) | 2007-07-04 | — | — | CN | disclosed |
| CN-1993332-A | Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (CH) | 2007-07-04 | — | — | CN | disclosed |
| EP-1773790-A1 | BENZYLTRIAZOLONE COMPOUNDS AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2007-04-18 | — | — | EP | disclosed |
| US-20060025462-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2006-02-02 | — | — | US | disclosed |
| WO-2006010545-A1 | BENZYLTRIAZOLONE COMPOUNDS AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207688-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | MAVS, IRF3, ZC3HAV1 | CALM1 4010/4885DAO 2175/4885SORT1 4801/4885 |
| US-20060025462-A1 | Heterocyclic antiviral compounds | MAVS, IRF3, ZC3HAV1 | CALM1 3610/4885DAO 2535/4885SORT1 4852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.